Magnolin promotes autophagy and cell cycle arrest via blocking LIF/Stat3/Mcl-1 axis in human colorectal cancers

Area of Science:

• Oncology
• Molecular Biology
• Natural Products Chemistry

Background:

• Colorectal cancer (CRC) remains a significant global health challenge.
• The precise anti-cancer mechanisms of natural compounds like magnolin require further elucidation.
• Understanding molecular pathways is crucial for developing novel CRC therapies.

Purpose of the Study:

• To investigate the anti-cancer effects of magnolin in human colorectal cancer (CRC) cells.
• To elucidate the molecular mechanisms underlying magnolin's action, focusing on autophagy and cell cycle regulation.
• To evaluate the therapeutic potential of magnolin in preclinical CRC models and correlate molecular findings with clinical data.

Main Methods:

• In vitro studies using CRC cell lines treated with magnolin, autophagy inhibitors (3-methyladenine), and siRNA for LC-3B.
• In vivo studies using xenograft models to assess tumor growth suppression and toxicity.
• Molecular analyses including gene expression, Western blotting (for p-Stat3 and Mcl-1), and correlation analysis with clinical CRC patient tissues.
• Evaluation of the leukemia inhibitory factor (LIF)/Stat3/Mcl-1 signaling pathway.

Main Results:

• Magnolin significantly suppressed CRC cell proliferation by inducing autophagy and cell cycle arrest.
• Autophagy activation and cell cycle arrest were dependent on LC-3B and abrogated by autophagy inhibitors.
• Magnolin treatment led to decreased LIF, p-Stat3, and Mcl-1 levels, implicating the LIF/Stat3/Mcl-1 pathway.
• In vivo studies demonstrated tumor growth inhibition by magnolin without apparent toxicity.
• Elevated LIF, p-Stat3, and Mcl-1 expression correlated with poor prognosis in CRC patients.

Conclusions:

• Magnolin exerts anti-cancer effects in CRC by activating autophagy and inducing cell cycle arrest.
• The mechanism involves the downregulation of the LIF/Stat3/Mcl-1 signaling pathway.
• Magnolin shows promising therapeutic potential for colorectal cancer treatment.